In conclusion we show the developmental expression of CYP2W1 in the GI tract, to a great extent mediated by epigenetic modifications, its specific location, and regulation by anticancer drugs which can be considered as an adjuvant therapy of colon cancer metastases and hepatic cancers in the future. This evidence concerns the gene CYP2W1 and malignant colon neoplasm.